“It is imperative that women do their homework when evaluating options for treatment of pelvic organ prolapse. Transvaginal mesh procedures play a pivotal role in preventing additional surgical intervention down the road but it is vital that they are performed by physicians who have been adequately trained,” said Sherrie Palm, Founder and President of the Association for Pelvic Organ Prolapse Support.
Mid-life can be a challenging time for thousands of women who find that they can no longer take their pelvic health or wellness for granted. Whether childbirth or aging one of the most common conditions women find themselves coping with is pelvic organ prolapse.
Pelvic organ prolapse is when one or more of the pelvic organs including the uterus, vagina, bladder, or rectum, fall down or slip out place. Twenty to 30 percent of women suffer from some degree of prolapse . Approximately 300,000 women undergo surgery each year for pelvic organ prolapse in the United States, according to the American Uroynecological Society
In 2008, the FDA first released concerns about the safety of transvaginal placement of mesh. From 2008 to 2010, the FDA received five times as many adverse reports associated with mesh used for POP repair than what agency received from 2005 to 2007.
“As advocates for patients with pelvic floor disorders, it’s important for us to be a voice for women who have found relief from this particular treatment along with those who have reported complications,” said Missy Lavender, Founder of Women’s Health Foundation . “Any surgical procedure is risky, it’s important that patients have a knowledge base of the ‘what if’s’ and have exhausted other less invasive treatment options.”
Please join Kelley Connors, MPH, host of Real Women on Health, in a conversation with Missy and Sherrie to find out what the options are when considering surgery for pelvic organ prolapse.
The on-line radio show will be held on Wednesday, August 24th at 11:30 am CST for 30 minutes. Please dial in to 1-646-929-2625 to share your voice and story around this important issue that will be soon discussed in an FDA hearing.